Lyka Labs Q2 FY27 Net Profit Soars 136% to ₹131.50 Lacs; Revenue Up 34%
Lyka Labs reported a 136% rise in standalone Q2 FY27 net profit to ₹131.50 Lacs and a 139% rise in consolidated net profit to ₹127.11 Lacs. Standalone revenue grew 34% to ₹4,419.95 Lacs. The company also saw significant growth in H1 FY27 results.
The significant percentage increase in net profit and revenue, along with improved EBITDA margins, suggests a strong positive impact on the company's financial health and investor sentiment.
The company has reported substantial year-on-year growth in both net profit and revenue for the second quarter and half-year ended September 30, 2026, indicating strong financial performance.
Lyka Labs Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The company reported a significant increase in its standalone net profit for Q2 FY27, surging by 136.32% to ₹131.50 Lacs, compared to a loss of ₹362.07 Lacs in the same period last year. Consolidated net profit also saw a substantial rise of 139.54% to ₹127.11 Lacs from a loss of ₹321.44 Lacs in Q2 FY26.
Standalone revenue from operations for the second quarter grew by 34.06% to ₹4,419.95 Lacs, while consolidated revenue from operations increased by 20.56% to ₹4,419.95 Lacs. The EBITDA margin for standalone operations improved to 9.49% in Q2 FY27 from (5.63)% in Q2 FY26, and for consolidated operations, it rose to 9.37% from (3.95)%. For the first half of FY27, standalone revenue from operations increased by 39.20% to ₹8,650.89 Lacs, and consolidated revenue from operations grew by 24.14% to ₹8,650.89 Lacs.
Standalone net profit for H1 FY27 rose by 221.55% to ₹341.53 Lacs, compared to a loss of ₹280.99 Lacs in H1 FY26. Consolidated net profit for H1 FY27 increased by 249.57% to ₹331.77 Lacs from a loss of ₹221.81 Lacs in the prior year. Revenue analysis shows that domestic revenue for Q2 FY27 was up 12.89% at ₹2,948.90 Lacs, and export revenue saw a significant jump of 51.89% to ₹1,415.49 Lacs. For H1 FY27, domestic revenue increased by 14.30% to ₹5,601.01 Lacs, and export revenue grew by 59.74% to ₹2,898.92 Lacs. The Board of Directors approved these financial results on October 30, 2026.
What to do with a filing like this
Lyka Labs Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lyka Labs Limited. Read the original for the full detail.